MOSL: HEALTHCARE-Slow pick-up in growth; High base affects volume growth
HEALTHCARE: Slow pick-up in growth; High base affects volume growth
- Indian Pharmaceutical Market's (IPM) secondary sales growth picked up 10.4% YoY in Apr'19 v/s 8.9% YoY in Mar'19, driven by prices (+5.2% YoY), volumes (+2.8% YoY), and new launches (+2.4% YoY).
- For the quarter ended Apr'19, IPM growth was at 9.8% YoY, supported by prices (+5.1% YoY), volumes (+2.4% YoY) and new product launches (+2.4% YoY).
- YoY growth on a MAT basis came in at 9.9% (9.6% in Mar'19) for the 12M ended Apr'19 (volumes: +3.4% YoY; prices: +4.1% YoY; new product launches: +2.3% YoY).
Price - key growth driver; new launches growth remains capped
- In value terms, secondary sales grew 10.7% YoY for non-DPCO products (86% of IPM) and 8.5% YoY for DPCO-listed products (10% of IPM) in the month.
- Growth in non-DPCO products was driven by prices (+5.4% YoY), volumes (+2.6% YoY) and new products (+2.7% YoY).
Motilal Oswal Financial Services Ltd. is a reputed name in Financial Services and Online Trading with group companies providing services such as Private Wealth Management, Retail Broking and Distribution, Institutional Broking, Asset Management, Investment Banking, Private Equity, Commodity Broking, Currency Broking, Principal Strategies & Home Finance.
Motilal Oswal Securities is a group company of Motilal Oswal Financial Service Limited which started as a stock trading company and has blossomed into well diversified firm offering a range of financial products and services. Motilal Oswal has built a reputation as the source for best stock trading company and this has taken a wealth of experience, knowledge and expertise, constantly working in tandem, over the years.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.